HRTS ETF
Tema Heart & Health ETF
HRTS ETF Overview
HRTS ETF (Tema Heart & Health ETF) is managed by Tema Global Limited with $54.2M in net assets. HRTS expense ratio is 0.75%, holding 92 positions across sectors including Health Care, Financials. Inception date: 2023-11-20.
HRTS performance shows a YTD return of 5.43%. The 1-year return is 27.51%. HRTS dividend yield stands at 1.27%, paid annually.
HRTS top holdings include Eli Lilly & Co. (11.2%), Thermo Fisherscientific Inc. (5.2%), Unitedhealth Group Incorporated (5.1%), Novo Nordisk As (4.7%), Merck & Company Inc (4.3%). Go to all HRTS holdings, HRTS sectors, or HRTS dividends.
HRTS can be compared against other funds. Use HRTS overlap to find shared positions, or HRTS vs another fund for a side-by-side view. HRTS alternatives are available via the screener, along with tax-loss harvesting opportunities.